Home LiteratureArticle Details
PMID: 3190987 Published · ppublish English Journal Article

Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.

British journal of clinical pharmacology ·Vol. 26 ·No. 4 ·1988-10-00 ·Pages 373-84

Schellens JH, van der Wart JH, Danhof M, van der Velde EA, Breimer DD

Abstract

1. Three model substrates for the characterization of drug oxidation activity, antipyrine (AP), hexobarbitone (HB) and theophylline (TH), were administered to 26 healthy volunteers on two different occasions: in the first experiment a combination of AP (250 mg) and HB (250 mg) was given and in the second experiment TH (150 mg) was added to the former combination. 2. Plasma concentrations of AP, HB and TH and urinary excretion of TH and the three main metabolites of AP (3-hydroxymethylantipyrine: HMA, norantipyrine: NORA and 4-hydroxyantipyrine: OHA) were determined and the intrinsic clearance (CLint) of the three substrates and the clearance to the formation of AP metabolites were calculated. 3. The correlation coefficients between CLHB and CL-greater than metabolites of AP were highest for CL-greater than HMA and CL-greater than NORA (greater than 0.80) and lowest for CL-greater than OHA (0.63). High correlation coefficients also were found between CLTH and CL-greater than OHA (0.89) and CL-greater than HMA (0.80). 4. Ideal relationships, defined by a slope of the orthogonal regression line equal to unity, did exist between CLHB and CL-greater than HMA as well as CL-greater than NORA and between CLTH and CLAP as well as CL-greater than OHA. 5. Based on the results of correlation and regression analysis it can be concluded that isozymes of the cytochrome P-450 system responsible for the oxidation of HB and formation of HMA and NORA are very closely related and also that isozymes responsible for the oxidation of TH and formation of OHA show a very close relation. 6. With this strategy of simultaneous administration of substrates ('cocktail' approach) it seems possible to characterize and correlate activities of different P-450 isozymes and to investigate their in vivo substrate selectivity without the disturbing influence of intra-individual variation in drug oxidation.

MeSH Terms
Adult Antipyrine/administration & dosage,metabolism,pharmacokinetics Contraceptives, Oral/pharmacology Female Hexobarbital/administration & dosage,metabolism,pharmacokinetics Humans Male Metabolic Clearance Rate Oxidation-Reduction Regression Analysis Sex Factors Smoking/metabolism Theophylline/administration & dosage,metabolism,pharmacokinetics
Chemicals
Contraceptives, Oral Hexobarbital Theophylline Antipyrine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Schellens J H
Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, Leiden, The Netherlands.
van der Wart J H
Danhof M
van der Velde E A
Breimer D D
References (26)
26 references, click to expand
  1. Differential induction of antipyrine metabolism by rifampicin.
    Eur J Clin Pharmacol. 1981;21(2):155-60 PMID: 7341283
  2. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
    Br J Clin Pharmacol. 1981 Dec;12(6):771-7 PMID: 7340879
  3. Assessment of the drug metabolism capacity of the liver.
    Br J Clin Pharmacol. 1982 Nov;14(5):631-51 PMID: 6128018
  4. Variability in caffeine metabolism.
    Clin Pharmacol Ther. 1983 May;33(5):591-602 PMID: 6687705
  5. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.
    Br J Clin Pharmacol. 1983 May;15(5):567-9 PMID: 6860533
  6. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
    J Pharmacol Exp Ther. 1983 Jun;225(3):747-51 PMID: 6134816
  7. Interindividual variations in drug disposition. Clinical implications and methods of investigation.
    Clin Pharmacokinet. 1983 Sep-Oct;8(5):371-7 PMID: 6627809
  8. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
    J Pharmacol Exp Ther. 1983 Nov;227(2):459-65 PMID: 6631725
  9. Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine.
    J Chromatogr. 1983 Dec 9;278(2):367-78 PMID: 6668316
  10. New directions in pharmacogenetics: Introduction.
    Fed Proc. 1984 May 15;43(8):2319-25 PMID: 6714440
  11. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
    Clin Pharmacol Ther. 1984 Jun;35(6):815-21 PMID: 6734034
  12. Theophylline-rifampicin interaction: non-selective induction of theophylline metabolic pathways.
    Br J Clin Pharmacol. 1984 Sep;18(3):445-8 PMID: 6487483
  13. Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.
    Br J Clin Pharmacol. 1984 Nov;18(5):701-6 PMID: 6508979
  14. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
    J Pharmacol Exp Ther. 1985 Jun;233(3):770-5 PMID: 4009489
  15. Simple linear regression in medical research.
    N Engl J Med. 1985 Dec 26;313(26):1629-36 PMID: 3840866
  16. An improved synthesis of 3-hydroxymethylantipyrine using antipyrine as starting material.
    Arzneimittelforschung. 1986 Mar;36(3):419-21 PMID: 3707658
  17. Correlation of apparent intrinsic clearances of simultaneously administered S (+) and d3R (-) hexobarbital in the rat.
    Biochem Pharmacol. 1987 Apr 15;36(8):1321-3 PMID: 3593417
  18. Pharmocokinetics of hexobarbital in man after intravenous infusion.
    J Pharmacokinet Biopharm. 1975 Feb;3(1):1-11 PMID: 1127574
  19. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
    Clin Pharmacol Ther. 1976 Dec;20(6):643-53 PMID: 991535
  20. Fitting straight lines when both variables are subject to error.
    Life Sci. 1978 Apr 3-17;22(13-15):1305-60 PMID: 661506
  21. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.
    Pharmacology. 1979;18(4):210-23 PMID: 461498
  22. The antipyrine test in clinical pharmacology: conceptions and misconceptions.
    Clin Pharmacol Ther. 1979 Sep;26(3):275-86 PMID: 111889
  23. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Xenobiotica. 1979 Nov;9(11):695-702 PMID: 119355
  24. Cigarette smoking and theophylline clearance and metabolism.
    Clin Pharmacol Ther. 1981 Oct;30(4):491-6 PMID: 7285483
  25. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    J Pharmacol Exp Ther. 1982 Jan;220(1):120-6 PMID: 7053408
  26. Influence of sex and oral contraceptive steroids on antipyrine metabolite formation.
    Clin Pharmacol Ther. 1982 Aug;32(2):240-6 PMID: 7094512
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1988-10-00
Pages
373-84
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1386557
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com